Cyclo Therapeutics, Inc. (CYTH) has 37 open-market insider trades by 7 insiders since 2020. The most active filer is Francis Patrick Ostronic, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rafael Holdings, Inc. | 10% Owner | — | 1 | $5.0M | 2024-12-23 |
| N. Scott Fine | CEO | — | 7 | $584K | 2023-10-20 |
| Francis Patrick Ostronic | Dir | — | 18 | $496K | 2025-02-27 |
| Markus Sieger | Dir | — | 4 | $214K | 2025-02-27 |
| Jeffrey Tate | COO | — | 4 | $48K | 2023-10-20 |
| Sharon Hemond Hrynkow | Chief Scientific Officer | — | 2 | $12K | 2021-12-02 |
| Joshua M. Fine | CFO | — | 1 | $370 | 2021-03-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rafael Holdings, Inc. | 10% Owner | Buy | $5.0M | 2023-08-01 |
| N. Scott Fine | CEO | Buy | $425K | 2023-04-20 |
| Francis Patrick Ostronic | Director | Buy | $43K | 2023-04-20 |
| Jeffrey Tate | COO | Buy | $21K | 2023-04-20 |
| Francis Patrick Ostronic | Director | Buy | $9K | 2022-09-21 |
| Francis Patrick Ostronic | Director | Buy | $10K |
Companies that share insiders with CYTH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-05-20 |
| Jeffrey Tate | COO | Buy | $6K | 2022-05-16 |
| Jeffrey Tate | COO | Buy | $5K | 2022-04-28 |
| Markus Sieger | Director | Buy | $27K | 2022-03-29 |
| N. Scott Fine | CEO | Buy | $37K | 2022-02-07 |
| Francis Patrick Ostronic | Director | Buy | $8K | 2022-01-24 |
| N. Scott Fine | CEO | Buy | $19K | 2022-01-19 |
| Francis Patrick Ostronic | Director | Buy | $5K | 2022-01-19 |
| Francis Patrick Ostronic | Director | Buy | $9K | 2022-01-14 |
| Francis Patrick Ostronic | Director | Buy | $7K | 2022-01-14 |